AVIDITY BIOSCIENCES, INC.
Clinical trial NCT07008469 updates: 1. primary completion date: 2030-08-01 → 2030-10-01 2. enrollment: 230 → 199 participants
Clinical trial NCT07008469 updates: 1. primary completion date: 2030-08-01 → 2030-10-01 2. enrollment: 230 → 199 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical